Identification of transcription factors that directly convert pluripotent stem cells (PSCs) into endothelial and blood cells and advances in the chemical modifications of messenger RNA (mRNA) offer alternative nucleic acid-based transgene-free approach for scalable production of these cells for drug screening and therapeutic purposes. Here we evaluated the effect of 5′ and 3′ RNA untranslated regions (UTRs) on translational efficiency of chemically-modified synthetic mRNA (modRNA) in human PSCs and showed that an addition of 5′UTR indeed enhanced protein expression. With the optimized modRNAs expressing ETV2 or ETV2 and GATA2, we are able to produce VE-cadherin + endothelial cells and CD34 + CD43 + hematopoietic progenitors, respectively, from human PSCs as well as non-human primate (NHP) PSCs. Overall, our findings provide valuable information on the design of in vitro transcription templates being used in PSCs and its broad applicability for basic research, disease modeling, and regenerative medicine.
Introduction
Pluripotent stem cell (PSC) technologies have opened possibilities for generation of patient-specific cells and tissues for the study of diseases and therapeutic applications. Typically, PSC differentiation protocols employ morphogens and growth factors to induce differentiation. However, recent advances in identification of key transcriptional regulators involved in cell fate commitment make it possible to directly convert somatic cells [1] [2] [3] and PSCs [4] to desired cell lineage simply by forced expression of transcription factors. Nevertheless, the widely used viral gene delivery systems are associated with genome integration and reactivation of the viral proteins, making it unsafe for therapeutic purposes. In recent years, advances in chemical synthesis have improved the stability of synthetic RNA to allow its use in nucleic acid transfer [5] . Use of modRNA is currently an attractive alternative and has become more prevalent in many applications [5] [6] [7] [8] [9] . However, further optimization of mRNA stability and translational efficiency would be essential to advancing modRNA-based technologies for in vitro PSC differentiation.
Because mRNA untranslated regions (UTRs) are known to regulate gene expression and affect translation in eukaryotic cells, different UTR modifications have been proposed to increase translational efficiency of modRNA. Guanine (G)-rich nucleic acid sequences are prevalent in the human genomes [10] . Located within the 5′-UTR of the RNA, these sequences form stable four-stranded secondary structures called G-quadruplexes and inhibits NRAS protein expression in vitro [11] suggesting that 5′UTR might be unfavorable for the modRNA. Recent demonstration that effects of UTRs on modRNA translation depends on cell type [6] , suggests that evaluation of the UTR impact should be performed using the appropriate target cells. Although several research using different types of modRNA has been published in somatic cells, its optimization has not yet determined in the PSCs. In present study, we evaluated the translational efficiency of modRNA synthesized from different in vitro transcription (IVT) templates encoding enhanced green fluorescence protein (eGFP) and demonstrated that modRNA containing 5′UTR and single 3′UTR is most efficiently translated into protein in human PSCs. Additionally, neither of the modifications affected eGFP half-life.
Recently, we revealed that human PSCs can be converted to endothelial cells by overexpression of ETV2, while overexpression of ETV2 and GATA2 using lentiviral or modRNA gene delivery lead to formation of multipotent CD34 + CD45 + hematopoietic progenitors [4] . We adopted the optimized modRNA expressing ETV2 or ETV2 and GATA2 to generate endothelial and hematopoietic cells, respectively, from human PSCs under defined xeno-free conditions. In addition, we showed that similar approach can successfully produce endothelial and hematopoietic cells from non-human primate (NHP) induced PSC (iPSC).
Materials and Methods

Cell Culture
Human embryonic stem cell (WA01), bone marrow-derived iPSC (IISH2i-BM9), and fibroblast-derived iPSC (DF19-9-7T) were all procured from WiCell (Madison, WI). Nonhuman primate iPSC (MnCy0669 iPSC) was previously derived by our group [12] . Human bone marrow and cord blood mononuclear cells from healthy donors were purchased commercially from Cell Processing Core (Cincinnati, OH). All PSCs were cultured on vitronectin-coated tissue culture plates in E8 medium (Stem Cell Technologies) [13] and an addition of 2.5 µM of IWR1 (ApexBio Technology) for MnCy0669 iPSC. Cells were subcultured every 4-5 days using 0.5 mM EDTA in PBS. For modRNA transfection, single cell suspension was prepared using either HyQTase (HyClone, UT) or Accutase (Innovative Cell Technologies, San Diego, CA). Endothelial cells were cultured on collagen coated-plate with endothelium medium (Cell Science).
Construction of In Vitro Transcription (IVT) Templates
All vectors and their RNA transcripts are shown in Fig. 1a , b. A series of vectors for the IVT was modified from pGEM-T Easy (Promega, Madison, WI). In brief, a cassette of 5′UTR of β-globin and multiple cloning sites (MCS) was synthesized by GeneArt service (Thermo Fisher Scientific) and cloned into the AatII/SpeI restriction sites of pGEM-T Easy. A single or double fragment of β-globin 3′UTR was inserted downstream of the MCS to generate 5′-MCS-1β and 5′-MCS-2β constructs respectively. AatII/BamHI restriction followed by blunt-end ligation was performed to generate MCS-1β and MCS-2β. eGFP flanked by BamHI restriction sites was cloned into the MCS of each constructs. Human ETV2 transcript variant 1(NM_014209.3) and GATA2 isoform 1 (NM_001145661.1) were cloned into 5′-MCS-1β construct to generate IVT template for ETV2. To generate IVT templates with 120-A tract, a reverse primer containing 120 T base pairs and forward primer were used in a PCR reaction (primers are listed in Supplemental Table 1 ). All the PCR reactions were carried out using Phusion (Thermo Fisher Scientific), 30 cycles of 95 °C for 10 s; 52 °C for ETV2; 58 °C for GATA2 for 10 s; 72 °C for 50 s. PCR products were run on the agarose gel and extracted using QIAEX II gel extraction kit (Qiagen, Valencia, CA) before further processing.
Synthesis of modRNA
modRNA was synthesized using the MEGAscript T7 kit (Ambion, Austin, TX), using a custom ribonucleoside cocktail comprising 3′-0-Me-m7G(5′)ppp(5′)G ARCA cap analog, pseudouridine triphosphate (TriLink Biotechnologies, San Diego, CA), adenosine triphosphate, guanosine triphosphate and cytidine triphosphate. The synthesis reactions were setup according to the manufacturer's instructions. Reactions were incubated 3 h at 37 °C and DNAsetreated. RNA was purified using PureLink RNA Micro kit (Thermo Fisher Scientific) and adjusted with RNase-free water to 100 ng/µl working concentration before freezing at − 80 °C.
eGFP Virus Production
PCR product of eGFP was subcloned into pSIN/EF1α lentiviral expression vector. Virus production was carried out by calcium phosphate transfection of Lenti-X 293T cells (Clontech, Mountain View, CA). Packaged lentiviral units were concentrated using Amicon Ultra-15 Centrifugal Filter Units (Millipore, Billerica, MA). Viral titer was assessed by transduction of Lenti-X 293T cells.
modRNA Transfection
For eGFP optimization, a total of 5 × 10 4 WA01 single cell suspension in basal E8 medium was transfected with 200 ng of RNA using TransIT-mRNA (Mirus Bio, Madison, WI) according to the manufacturer's instructions. Cell/RNA mixture was plated into one well of vitronectin-coated 24-well plate. Complete E8 medium was added to bring total volume to 550 µl/well. ROCK inhibitor (StemCell Technologies, Vancouver, Canada) was added at 10 µM to improve cell viability as described in [4] . eGFP virus with a titer of 7 × 10 7 transducing unit/ml was used at 1 µl per well, and complete medium was changed 24 h after transduction. For direct induction of endothelial cells, 2 × 10 5 of indicated cells were transfected with 200 ng of ETV2 modRNA and cultured in vitronectincoated 6-well plate. For generation of hematopoietic cells, 2 × 10 5 of indicated cells were transfected with 400 ng of each ETV2 and GATA2 modRNA and cultured under the same conditions. After 24 h, cells were harvested with Accutase and transferred to collagen coated 6-well plate in IF9S medium [14] supplemented with hematopoietic cytokines including 10 ng/ml IL3, 20 ng/ml FGF2, 50 ng/ ml VEGF, Il6, SCF, and TPO. Second transfection was performed on the same day with 400 ng of each modRNA.
Flow Cytometry
Cells were harvested using Accutase and stained with Ghost Dye™ (Tonbo Biosciences, Madison, WI), CD31, CD34, and CD144 (BD Bioscience) for 30 min at 4 °C. Cells were washed before analyses using MACSQuant Analyzer 10 (Miltenyi Biotec Inc, San Diego, CA). Non-transfected cell was included to establish a threshold for positive gating. Single live cells were gated and analyzed by FlowJo software (Tree Star, Ashland, OR). eGFP positive cells were gated for the quantitative measurement of mean fluorescence intensity (MFI).
Live Staining of Endothelial Cells and AcLDL Uptake Assay
ETV2-transfected cells were transferred to a collagen-coated plate and cultured in endothelial medium (PromoCell). Ten µg/ml of Alexa-594-conjugated AcLDL (Thermo Fisher Scientific) was added to culture at 24 h after transfection and incubated at 37 °C for 4 h as previously described [4] . VEcadherin was then added to the culture and incubated on the rocker at room temperature for 15 min. Cells were washed twice with PBS prior to fluorescence imaging.
Colony-Forming Cell Assay
CFC assays were performed in 35-mm low-adherent culture dishes (StemCell Technologies) using MethoCult 4435 (StemCell Technologies). Colonies were scored after 14 days of incubation. Wright staining was used to evaluate the morphology of cells within colonies on cytospins.
Statistical Analysis
Data obtained from multiple experiments were reported as mean ± SD. Significant levels were determined by one-way ANOVA followed by Tukey post hoc test as appropriate. p < 0.05 was considered significant. All the graphs and statistics were performed using GraphPad Prism software (GraphPad, San Diego, CA).
Results
Optimization of In Vitro Transcription (IVT) Template for RNA Synthesis
The translational efficiency of mRNA is tightly regulated to ensure a proper amount of protein is being produced at the right time and terminated when the cells no longer need it. 5′ and 3′UTR have been shown to play important roles in the regulatory mechanics during the translational process (i.e., initiation, elongation, and termination) and posttranslational modifications. Initially, the ribosomal complex is formed at the 5′UTR by a direction of the cap-binding protein eIF4F complex, which is a rate-limiting step of capdependent initiation (reviewed in [15] ). Kozak demonstrated that the α-and β-globin 5′UTR can impact translational efficiency [16] , and alternative splice variants of the 5′UTR can affect translation of the bovine growth hormone receptor over an 80-fold range [17] . 5′UTR together with 3′UTR, which contains AU-rich elements, polyadenylation signals, cis-and trans regulatory elements, offer an unlimited range of control possibilities within a single mRNA that influences polyadenylation, translation efficiency, localization, and stability of the mRNA (reviewed in [18] ).
Despite current understanding of translational control regulation, precise roles of the UTRs on translational efficiency in human PSCs have not been systematically demonstrated. To evaluate the effect of UTRs on translational efficiency of modRNA, we generated 4 different eGFP-encoding in vitro transcription (IVT) templates with and without 5′UTR. We also incorporate 2 repeats of artificially added β-globin 3′UTR into the templates (Fig. 1a, b) . To assess how different mRNA modifications affect the onset, duration and the level of gene expression, we transfected WA01 human PSC line with modRNA synthesized from all IVT templates and analyzed eGFP expression by immunofluorescense and flow cytometry. We observed that the onset of eGFP expression was approximately 90 min after transfection regardless of the modifications, but the fluorescence intensity became decent for imaging after 2 h (Fig. 1c) . In contrast, the signal intensity from lentivirus remained low at 24 h after transduction (Fig. 1d) . We found that IVT modifications did not affect transfection efficiency (> 90% for all modifications) (Fig. 2a,  b) . However, in contrast to previous findings in dendritic cells [9] , we found the presence of 5′UTR of human β-globin gene significantly improved eGFP protein levels at 24 h after transfection, whereas artificially added repeat of β-globin 3′UTR significantly diminished maximum eGFP intensity (Fig. 2c) .
To precisely evaluate the impact of these modifications on the level of protein expression, we performed time kinetic study of eGFP expression at a single cell level using flow cytometry. We found that eGFP intensity reached maximum level at 24 h after transfection and started declining after since prior to fading out by day 7 (Fig. 2c, d) . Neither of the modification showed significant advantages over the others in term of duration of eGFP expression suggesting the modifications did not significantly affect RNA stability in WA01. We observed that the first 72 h is a golden period for modRNA gene delivery showing high protein expression compared to lentivirus. In contrast, the signal from lentiviral delivery was increasing and reached steady expression at 96 h (Fig. 2c) . In principle, the time kinetic curve of eGFP represents the summation of several cellular processes such as mRNA transfer rate, distribution, and protein degradation. While the early phase of the plot involves protein production and degradation, the late phase generally represents the degradation of the protein [19] . We further analyzed time kinetic data to evaluate whether modifications of IVT transcripts affect a protein half-life. Based on degradation pattern analyses of the eGFP fluorescence intensity from all modifications, we found that eGFP was a stable protein of which its ). eGFP MFI were plotted on a log scale vs. time. Data represents mean ± SD from 3 experiments degradation followed first-order kinetics (Fig. 2e, R 2 > 0.95); A(t) = A 0 e − kt where A(t) is a mean fluorescence intensity (MFI) at time t, A 0 is MFI at time 0, k is a constant of decay. To accurately estimate eGFP half-life, we used data from the late phase of the kinetic curve (24-96 h) where protein decay is the major process. Although eGFP products were encoded from different IVT templates, they are theoretically the same protein. In agreement with Corish et al. [20] , our estimated eGFP half-life was ~ 26 h (average from all IVT templates) ( Table 1) .
Next, we assessed whether similar modifications of RNA have similar effect in NHP. Using the same set of modRNAs, we found a significant increase in expression of eGFP when 5′UTR is present. However, in contrast to human PSCs, we did not observe decline in eGFP signal following addition of the extra repeat of β-globin 3′UTR (Supplemental Fig. 1 ). Overall these experiments revealed that 5′UTR and single 3′UTR allow superior protein expression in human and NHP iPSCs. Thus, we selected this modification for our endothelial and blood cell induction experiments.
Generation of Endothelial Cells and Hematopoietic Progenitors from PSCs
ETS variant 2 (ETV2) is well-known as a single transcription factor essential for endothelial program [4, 21, 22] . Our group previously demonstrated that using lentiviral vector to force express a single transcription factor ETV2 in pluripotent stem cells requires 48 h after transduction to bypass mesodermal stage and become endothelial cells. Since modRNA can directly translate into protein, we evaluate whether this process could be reproduced more rapidly. We synthesized ETV2 modRNA from the optimized IVT template containing 5′UTR and single 3′UTR and performed a single transfection using a cationic polymer/ lipid reagent. Twenty-four hours after transfection with the ETV2 modRNA, morphology of pluripotent stem cells from 3 irrelevant human PSCs (WA01, IISH2i-BM9, and DF19-9-7T) and cynomolgus macaque MnCy0669 NHP-iPSC transformed into typical endothelial phenotype, acquired endothelial markers (CD31 and CD144 for human PSCs; CD31 for NHP iPSCs), and endocytosed AcLDL (Fig. 3a) . Interestingly, WA01 and IISH2i-BM9 achieved > 80% conversion efficiency while DF19-9-7T achieved > 40% yielding up to 3 × 10 5 cells on passage 0 (Fig. 3b, c) . These endothelial cells are able to expand under endothelial condition for up to 3 passages and retain their typical endothelial cell morphology (Fig. 3d) .
As we previously showed, overexpression of ETV2 and GATA2 in human PSCs induces formation of CD34 + CD45 + multipotent hematopoietic progenitors through hemogenic endothelium intermediates [4] . To further improve direct blood induction protocol and avoid the use of xenogenic components such as Matrigel, we evaluated the efficacy of blood production from different human PSCs lines in our new system which is based on vitronectin and collagen under serum-free and xeno-free conditions (Fig. 4a) . Following human PSC transfection with ETV2 and GATA2 modRNA, we observed the first hematoendothelial cluster as early as 4 days of culture. Flow cytometric analyses on day 7 after transfection showed that most of the early hematopoietic progenitors (CD34 + 43 + 45 + 235a − ) have detached from their parental endothelial cells and expand in suspended culture (Fig. 4b) . These cells are able to form typical granulocyte colony-forming cell (CFC, CFC-G), macrophage (CFC-M), and erythroid (CFC-E) colonies in clonogenic cultures (Fig. 4c) . Comparison of gene expression between endothelial/hematopoietic cells generated from our protocol and primary human cells (i.e., HUVEC, cord blood (CB), and bone marrow (BM) mononuclear cell) demonstrated similarity in molecular signature of endothelial (TIE2, FLI1, and SCL) and hematopoietic lineages (C-Kit, LMO2, and MYB) (Supplemental Fig. 2) .
We estimated to obtain 1-2 × 10 4 CD34 + CD43 + cells or 0.8-1.8 × 10 3 colony-forming cells from 2 × 10 5 initial undifferentiated human PSCs (Fig. 4d, e) . Similar combination of ETV2 and GATA2 modRNA induced formation of floating CD34 + hematopoietic cells from MnCy0669 iPSC. However, direct blood induction with modRNA from NHP iPSC growing under defined xeno-free condition was less efficient than from human iPSCs, probably due to lower efficiency of human transcription factors in NHP cells (Supplemental Fig. 3) .
Discussion
In these studies, we evaluated translational efficiency of different mRNA modifications in order to improve direct induction of endothelium and blood from PSCs. Using eGFP modRNA, we found that IVT template containing 5′UTR and single 3′UTR from β globin gene provided maximum protein levels in human PSCs while IVT template containing artificial two repeats of 3′UTRs yielded the least. The results indicated that the presence of β globin 5′UTR enhanced the translational efficiency of the transgenes, whereas double repeats of β globin 3′UTR is notably disadvantageous in human, but not in NHP iPSCs. Analysis of the β globin 5′UTR sequence reveals a low G-C content (44%) suggesting the potential of secondary structure formation that can suppress protein translation is unlikely. Point mutations within the 5′UTR of the β globin gene reduced the rate of transcription resulting in thalassemia diseases, but did not interfere with mRNA transport from the nucleus to the cytoplasm, 3′ end processing, and mRNA stability [23] . These findings indicate the translational enhancement mechanism interacts on the specific sequence within 5′UTR during the transcription process. We found neither of the modifications demonstrated any significant benefit on the duration of functional eGFP protein expression. Study in dendritic cells showed that β globin UTRs on modRNA contribute to the translational efficiency and RNA stability [6] ; however, they affect differently between immature and mature dendritic cells indicating the impact of UTRs is likely cell-type specific. The differences in modRNA stability were also observed in our studies, which revealed variable effect of double repeats of β globin 3′UTR in human and NHP iPSCs. Therefore, the impact of UTRs on translation should be determined on a cell-to-cell basis.
Currently available methods to generate hematoendothelial cells from PSCs are (a) embryoid body formation which is labor-intensive and time consuming [24, 25] , (b) monolayer differentiation [14, [26] [27] [28] which requires either hypoxic condition, stromal cells, or cytokine cocktail, and (c) direct programming using transcription factors [4, 21] . Since differentiation process is stochastic and depends on several factors, the generation efficiency become inconsistent between experiments and cell lines [29] . Here we showed that productions of endothelial and blood cells from PSCs can be achieved in defined conditions by using ETV2 or ETV2 and GATA2 modRNA, respectively. Compared to other protocols for endothelial and hematopoietic cell generation, our modRNA-based approach does not require morphogens and provides experimental consistency and reliability regardless of types of PSCs and species. Because we use defined conditions, our method allows a production of clinical-grade cells for therapeutics. Estimated cost of reagents including synthesis kit, modified nucleotide, cap analog, and transfection chemicals (not including medium and culture vessels) to generate approximately 1-2 × 10 5 endothelial cells from PSCs is much lower than typical differentiation protocol using combination of cytokines [14] . Additionally, these endothelial cells can be further expanded to obtain cells in large numbers.
Assessment on efficacy, safety, immunogenicity and toxicity of iPSC-based therapies in preclinical models would be essential to advance these technologies to the clinic. Demonstration in our studies that modRNA protocol can be adopted to generate endothelial and blood cells from NHP iPSCs, open opportunity to evaluate modRNA-induced blood and endothelial products in NHP preclinical model. In current studies, we used iPSCs from Mauritian cynomolgus monkeys. Mauritian cynomolgus macaques are descendent from a small founder population and have very limited MHC diversity consisting of only seven common haplotypes (M1-M7) [30] [31] [32] . This provides a unique opportunity to rapidly select MHC and blood group-identical animals, or animals with well-defined MHC/blood group mismatches by genetic screening to test immunogenicity of PSC-derived products.
Overall, our study will assist stem cell researchers in designing experiments to modulate gene expressions using modRNA and provides a scalable protocol to generate hematoendothelial cells from human and NHP iPSCs for a range of applications such as developmental study, disease modeling, high-throughput screening and eventually cellular therapies where the availability of large cell numbers is a key prerequisite.
